Hepatitis C performance measure on hepatitis A and B vaccination: Missed opportunities

American Journal of Gastroenterology

Volumn 104, Issue 8, 2009, Pages 1961-1967

  Hernandez, Bridget ^a   Hasson, Noelle K ^a   Cheung, Ramsey ^b,c  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b STANFORD UNIVERSITY   (United States)

^c Division of Gastroenterology and Hepatology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS A HEPATITIS B VACCINE; HEPATITIS A VACCINE; RECOMBINANT HEPATITIS B VACCINE; RECOMBINVAX; UNCLASSIFIED DRUG; VIRUS RNA;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; HEALTH CARE SYSTEM; HEPATITIS A; HEPATITIS A VIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNIZATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PRIORITY JOURNAL;

FEMALE; HEPATITIS A; HEPATITIS A VACCINES; HEPATITIS B; HEPATITIS B VACCINES; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; RETROSPECTIVE STUDIES;

EID: 68349150925     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2009.252     Document Type: Article

References (20)

1. Management of hepatitis C. NIH Consensus State Statements. 10-1. June 2002. Hepatology 2002; 36 (5 Suppl 1): S3-20.
2. Armstrong GL, Wasley A, Simard EP et al. The Prevalence of Hepatitis C Virus Infection in the United States, 199. through 2002. Ann Intern Med 2006;144:705-14.
3. Centers for Disease Control and prevention. Disease burden from Hepatitis A, B, and C in the United States., Available at http://www.cdc.gov/hepatitis/ Statistics.htm.
4. Dominitz JA, Boyko EJ, Koepsell TD et al. Elevated prevalence of hepatitis C infection in users of United States veterans medical centers. Hepatology 2005;41:88-96.
5. Vento S, Garofano T, Renzini C et al. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. N Engl J Med 1998;338:286-90.
6. Keeffe EB. Hepatits A and B superimposed on chronic liver disease: vaccine-preventable diseases. Trans Am Clin Climatol Assoc 2006;117:227-38.
7. Pramoolsinsap C, Poovorawan Y, Hirsch P et al. Acute, hepatitis-A superinfection in HBV carriers, or chronic liver disease related to HBV or HCV. Ann Trop Med Parasitol 1999;93:745-51.
8. Sagnelli E, Coppola N, Messina V et al. HBV superinfection in hepatitis C virus chronic carriers, viral interaction, and clinical course. Hepatology 2002;36:1285-91.
9. Advisory Committee on Immunization Practices (ACIP); Fiore AE, Wasley A, Bell BP. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006; 55 (RR-7):: 1.
10. Yee HS, Currie SL, Darling JM et al. Management and treatment of hepatitis C viral infection: Recommendations fro the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program Office. Am J Gastroenterol 2006;101:2360-78.
11. Keeffe EB, Williams J, for the Hepatitis C Work Group. Hepatitis C physician performance measurement set. Available at www.ama-assn.org/ama1.pub/ upload/mm/370/hepcws110607.pdf.
12. Arguedas MR, McGuire BM, Fallon MB. Implementation of vaccination in patient with cirrhosis. Dig Dis Sci 2002;47:384-7.
13. Saab S, Nguyen S, Ibrahim A et al. Management of patients with cirrhosis in Southern California: results of a practice survey. J Clin Gastroenterol 2006;40:156-61.
14. Shim M, Khaykis I, Park J et al. Susceptibility to hepatitis A in patients with chronic liver disease due to hepatitis C virus infection: missed opportunities for vaccination. Hepatology 2005;42:688-95.
15. Jacobs RJ, Meyerhoff AS, Saab S. Immunization needs of chronic liver disease patients seen in primary care versus specialist settings. Dig Dis Sci 2005;50:1525-631.
16. Wong V, Wreghitt TG, Alexander GJ. Prospective study of hepatitis B vaccination in patients with chronic hepatitis C. BMJ 1996;312:1336-7.
17. Hachem CY, Kramer JR, Kanwal F, El-Serag HB. Hepatitis vaccination in patients with hepatitis C: practice and validation codes at a large veterans administration medical center. Aliment Pharmacol Ther 2008;28:1078-87.
18. Jakiche R, Borrego ME, Raisch DW et al. The cost effectiveness of two strategies for vaccinating US Veterans with hepatitis C virus infection against hepatitis A and hepatitis B viruses. Am J Med Sci 2007;333:26-34.
19. Siddiqui F, Mutchnick M, Kinzie J et al. Prevalence of hepatitis A virus and hepatitis B virus immunity in patients with polymerase chain reaction-confirmed hepatitis C: Implications for vaccination strategy. Am J Gastroenterol 2001;96:858-63.
20. Arguedas MR, Heudebert GR, Fallon MB et al. The cost-effectiveness of hepatitis A vaccination in patient with chronic hepatitis C viral infection in the United States. Am J Gastroenterol 2002;97:721-8.